PRINCETON, N.J., Sept. 11 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP - News), an innovator in the discovery and development of novel small molecule therapeutics, today announced the appointments of Eric J. Liebler as Executive Vice President, Corporate Development and S. David Kimball, Ph.D., as Senior Vice President, Chemistry and Preclinical Chemical Development.
